HOME Top Market Reports Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: December 2017
Report Code: MD 5797

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


[182 Pages Report] The overall GI stent market is expected to grow from USD 337.5 million in 2016 to USD 452.6 million by 2022, at a CAGR of 5.1% from 2017 to 2022.

The growing prevalence of colorectal and other gastrointestinal cancers across the globe is expected to increase the demand for gastrointestinal stents, which will in turn drive growth in this market. Interventional endoscopy, including gastrointestinal stenting, provides immediate and effective palliation, which is essential for improving the quality of life of the affected patient. The rapidly increasing geriatric population, rising preference for minimally invasive procedures, rising prevalence of gastrointestinal cancers and gastrointestinal diseases, and changing lifestyle are the major factors driving the growth of gastrointestinal stents market. Development of biodegradable and drug-eluting stents and growing focus towards emerging markets offer significant growth opportunities in this market. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Market Dynamics

Drivers

  • Rising prevalence of gastrointestinal cancers and other digestive diseases
  • Rising geriatric population
  • Rising preference for minimally invasive procedures
  • Changing lifestyle

Opportunities

  • Development of biodegradable and drug-eluting gastrointestinal stents
  • Emerging markets

Challenges

  • Complications associated with gastrointestinal stent implementation

Rising prevalence of gastrointestinal cancers and other digestive diseases drives the global GI stent market

Gastrointestinal cancer is one of the leading causes of death worldwide. In the past few years, there has been a steep rise in the morbidity and mortality from chronic diseases such as esophageal cancer, colorectal cancer, and gastrointestinal-related critical disorders. The growing prevalence of colorectal and other gastrointestinal cancers across the globe is expected to increase the demand for gastrointestinal stents, which will in turn drive growth in this market. Interventional endoscopy, including gastrointestinal stenting, provides immediate and effective palliation, which is essential for improving the quality of life of the affected patient.

Gastrointestinal / GI Stent Market

The following are the major objectives of the study.

  • To define, describe, and forecast the global gastrointestinal stents market by product, material, disease type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the gastrointestinal stents market with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • To profile the key players in the global gastrointestinal stents market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as R&D activities; mergers and acquisitions; product developments; and expansions of key players in the global gastrointestinal stents market

During this research study, major players operating in the GI stent market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

Gastrointestinal / GI Stent Market

To know about the assumptions considered for the study, download the pdf brochure

The gastrointestinal stents market is highly diversified and competitive in nature. Some of the prominent players in this market are Boston Scientific Corporation (Boston Scientific) (US), C.R. Bard, Inc. (C.R. Bard) (US), ELLA - CS, s.r.o. (ELLA-CS) (Czech Republic), Becton, Dickinson and Company (Becton, Dickinson and Company) (US), Merit Medical Systems, Inc. (Merit Medical Systems) (US), CONMED Corporation (Conmed) (US), Cook Group Incorporated (Cook) (US), Cantel Medical Corp. (Cantel Medical) (US), Olympus Corporation (Olympus) (Japan), TaeWoong Medical Co., Ltd. (TaeWoong Medical) (South Korea), Micro-Tech (Nanjing) Co., Ltd. (Micro-Tech (Nanjing)) (China), ENDO-FLEX (ENDO-FLEX) (Germany), M.I.Tech (M.I.Tech) (South Korea), and Diagmed Healthcare Limited (Diagmed Healthcare) (UK).

Major Market Developments

  • In March 2016, Boston Scientific launched AXIOS Stent and Electrocautery Enhanced Delivery System in order to help the physicians treat pancreatitis by using minimally invasive surgery.
  • In July 2015, Micro-Tech (Nanjing) opened its subsidiary MICRO-TECH USA (US). This expansion signified MICRO-TECH΄s entry into the US market with its own branded GI endoscopy disposable products.
  • In April 2017, Becton, Dickinson and Company entered into an agreement to acquire C.R. Bard (US). This combination will create a highly distinguished medical technology company uniquely positioned to improve both the process of care and the treatment of diseases for patients and healthcare providers.

Target Audience

  • Manufacturers & distributors of gastrointestinal stents
  • Healthcare institutions (hospitals and Ambulatory Surgery Centers)
  • Contract manufacturing organizations
  • Research institutes
  • Government associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Report Scope

By Product

  • Biliary Stent
  • Duodenal Stent
  • Colonic Stent
  • Pancreatic Stent
  • Esophageal Stent

By Material

  • Self-expanding Metal Stent
  • Nitinol Stent
  • Stainless Steel Stent
  • Other Metal Stent
  • Plastic Stent

By Disease Type

  • Biliary Diseases
  • Inflammatory Bowel Diseases
  • Gastrointestinal Cancers
  • Colorectal Cancer
  • Stomach Cancer
  • Pancreatic Cancer
  • Esophageal Cancer

By End User

  • Hospitals
  • Ambulatory Surgery Centers

By Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of APAC
  • Latin America
  • Middle East & Africa

Critical questions which the report answers

  • What are new disease types which the GI stent companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the RoAPAC gastrointestinal stents market into South Korea, Australia, New Zealand, and others.
  • Further breakdown of the RoE gastrointestinal stents market into Belgium, Russia, the Netherlands, Switzerland, and others.

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primary Interviews: By Company Type, Designations, and Region
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Market Breakdown & Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)

4 Premium Insights (Page No. - 33)
    4.1 Gastrointestinal Stent Market: Overview
    4.2 Asia Pacific: Gastrointestinal Cancer Stents Market, By Product and Country
    4.3 Global Market, By Country
    4.4 Global Market, By Disease Type
    4.5 Regional Mix: Global Market

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Gastrointestinal Cancers and Other Digestive Diseases
                    5.2.1.2 Increasing Geriatric Population
                    5.2.1.3 Growing Preference for Minimally Invasive Procedures
                    5.2.1.4 Changing Lifestyles
           5.2.2 Restraint
                    5.2.2.1 Complications Associated With Gastrointestinal Stent Implementation
           5.2.3 Opportunities
                    5.2.3.1 Development of Biodegradable and Drug-Eluting Gastrointestinal Stents
                    5.2.3.2 Emerging Markets
    5.3 Reimbursement Scenario in the US
    5.4 Regulatory Analysis

6 Gastrointestinal Stent Market, By Product (Page No. - 50)
    6.1 Introduction
    6.2 Biliary Stents
    6.3 Colonic Stents
    6.4 Duodenal Stents
    6.5 Pancreatic Stents
    6.6 Esophageal Stents

7 Gastrointestinal Stent Market, By Material (Page No. - 60)
    7.1 Introduction
    7.2 Self-Expanding Metal Stents
           7.2.1 Nitinol Stents
           7.2.2 Stainless Steel Stents
           7.2.3 Other Metal Stents
    7.3 Plastic Stents

8 Gastrointestinal Stent Market, By Disease Type (Page No. - 69)
    8.1 Introduction
    8.2 Biliary Diseases
    8.3 Gastrointestinal Cancer
           8.3.1 Colorectal Cancer
           8.3.2 Pancreatic Cancer
           8.3.3 Stomach Cancer
           8.3.4 Esophageal Cancer
    8.4 Inflammatory Bowel Diseases

9 Gastrointestinal Stent Market, By End User (Page No. - 79)
    9.1 Introduction
    9.2 Hospitals
    9.3 Ambulatory Surgery Centers

10 Gastrointestinal Stent Market, By Region (Page No. - 84)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia Pacific
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia Pacific
     10.5 Latin America
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 141)
     11.1 Overview
     11.2 Market Ranking
     11.3 Competitive Scenario
     11.4 Developments
             11.4.1 Acquisitions
             11.4.2 Other Developments: Product Launch and Expansion
     11.5 Gastrointestinal Stent Market: Product Portfolio Analysis

12 Company Profiles (Page No. - 146)
(Business Overview, Products Offered, SWOT Anlysis, MnM View.)*
     12.1 Boston Scientific
     12.2 Cook Group
     12.3 Micro-Tech (Nanjing)
     12.4 Taewoong Medical
     12.5 Ella–CS
     12.6 C.R. Bard
     12.7 Becton, Dickinson and Company
     12.8 Merit Medical Systems
     12.9 Conmed
     12.10 Cantel Medical
     12.11 Olympus
     12.12 Endo-Flex
     12.13 M.I. Tech
     12.14 Diagmed Healthcare

*Business Overview, Products Offered, SWOT Anlysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 172)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (177 Tables)

Table 1 Incidence of Colorectal Cancer Worldwide, 2012
Table 2 Global Gastrointestinal Cancer Incidence, 2012
Table 3 Impact Analysis: Drivers
Table 4 Frequency of Most Common Stent-Related Complications
Table 5 Impact Analysis : Restraint
Table 6 Estimated Incidence and Mortality in Asia, By Cancer Type, 2012
Table 7 Incidence and Deaths Caused Due to Stomach Cancer, By Country, 2012
Table 8 Impact Analysis : Opportunities
Table 9 Hospital Outpatient and Asc Reimbursement (USD)
Table 10 Classification of Medical Devices and the Reviewing Body in Japan
Table 11 Global Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 12 Global Gastrointestinal Stent Market, By Country/Region, 2015–2022 (USD Million)
Table 13 Biliary Stents: Key Products Offered By Prominent Players
Table 14 Global Biliary Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 15 Colonic Stents: Key Products Offered By Prominent Players
Table 16 Global Colonic Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 17 Duodenal Stents: Key Products Offered By Prominent Players
Table 18 Global Duodenal Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 19 Pancreatic Stents: Key Products Offered By Prominent Players
Table 20 Global Pancreatic Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 21 Esophageal Stents: Key Products Offered By Prominent Players
Table 22 Global Esophageal Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 23 Global Gastrointestinal Stent Market, By Material, 2015–2022 (USD Million)
Table 24 Self-Expanding Metal Stents: Key Products Offered By the Prominent Players
Table 25 Global Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 26 Global Gastrointestinal Self-Expanding Metal Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 27 Global Nitinol Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 28 Global Stainless Steel Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 29 Global Other Metal Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 30 Plastic Stents: Key Products Offered By Prominent Players
Table 31 Global Plastic Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 32 Global Gastrointestinal Stent Market Size, By Disease Type, 2015–2022 (USD Million)
Table 33 Global Biliary Diseases Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 34 Global Gastrointestinal Cancer Stents Market, By Type, 2015–2022 (USD Million)
Table 35 Global Gastrointestinal Cancer Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 36 Global Colorectal Cancer Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 37 Global Pancreatic Cancer Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 38 Global Stomach Cancer Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 39 Global Esophageal Cancer Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 40 Global Inflammatory Bowel Diseases Stents Market, By Country/Region, 2015–2022 (USD Million)
Table 41 Global Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 42 Reimbursement in Hospital Outpatients for Ercp Stenting Procedures (USD)
Table 43 Global Hospitals Market, By Country/Region, 2015–2022 (USD Million)
Table 44 Number of Medicare-Certified Ascs in the US (2009–2014)
Table 45 Reimbursement in Asc for Ercp Stenting Procedures (USD)
Table 46 Global Ambulatory Surgery Centers Market, By Country/Region, 2015–2022 (USD Million)
Table 47 North America: GI Cancer Incidence in the Geriatric Population, (2012 vs 2030)
Table 48 North America: Gastrointestinal Stent Market, By Country, 2015–2022 (USD Million)
Table 49 North America: Market, By Product, 2015–2022 (USD Million)
Table 50 North America: Gastrointestinal Stent Market, By Material, 2015–2022 (USD Million)
Table 51 North America: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 52 North America: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 53 North America: Gastrointestinal Cancer Stents Market, By Type, 2015–2022 (USD Million)
Table 54 North America: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 55 US: Estimated Cases of Digestive System Cancer, By Type (2017)
Table 56 US: Macroeconomic Indicators
Table 57 US: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 58 US: Market, By Material, 2015–2022 (USD Million)
Table 59 US: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 60 US: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 61 US: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 62 US: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 63 Canada: Estimated Cases of Digestive System Cancer, By Type (2017)
Table 64 Canada: Macroeconomic Indicators
Table 65 Canada: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 66 Canada.: Market, By Material, 2015–2022 (USD Million)
Table 67 Canada: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 69 Canada: Gastrointestinal Cancer Stents Market, By Type, 2015–2022 (USD Million)
Table 70 Canada: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 71 Europe: Gastrointestinal Cancer Incidence Among Geriatric Population, By Type (2012 vs 2030)
Table 72 Europe: Gastrointestinal Stent Market, By Country/Region, 2015–2022 (USD Million)
Table 73 Europe: Market, By Product, 2015–2022 (USD Million)
Table 74 Europe: Gastrointestinal Stent Market, By Material, 2015–2022 (USD Million)
Table 75 Europe: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 76 Europe: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 77 Europe: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 78 Europe: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 79 Germany: Macroeconomic Indicators
Table 80 Germany: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 81 Germany: Market, By Material, 2015–2022 (USD Million)
Table 82 Germany: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 83 Germany: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 84 Germany: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 85 Germany: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 86 France: GI Cancer Incidence Among Geriatric Population, By Type (2012 vs 2030)
Table 87 France: Macroeconomic Indicators
Table 88 France: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 89 France: Market, By Material, 2015–2022 (USD Million)
Table 90 France: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 91 France: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 92 France: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 93 France: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 94 UK: Gastrointestinal Cancer Incidenceamong Geriatric Population, By Type (2012 vs 2030)
Table 95 UK: Macroeconomic Indicators
Table 96 UK: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 97 UK: Market, By Material, 2015–2022 (USD Million)
Table 98 UK: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 99 UK: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 100 UK: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 101 UK: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 102 Italy: Gastrointestinal Cancer Incidence Among Geriatric Population, By Type (2012 vs 2030)
Table 103 Italy: Macroeconomic Indicators
Table 104 Italy: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 105 Italy: Market, By Material, 2015–2022 (USD Million)
Table 106 Italy: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 107 Italy: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 108 Italy: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 109 Italy: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 110 Spain: GI Cancer Incidence Among Geriatric Population, By Type (2012 vs 2030)
Table 111 Spain: Macroeconomic Indicators
Table 112 Spain: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 113 Spain: Market, By Material, 2015–2022 (USD Million)
Table 114 Spain: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 115 Spain: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 116 Spain: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 117 Spain: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 118 RoE: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 119 RoE: Market, By Material, 2015–2022 (USD Million)
Table 120 RoE: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 121 RoE: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 122 RoE: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 123 RoE: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 124 Asia Pacific: GI Cancer Incidence and Mortality Rate, By Type, (2012)
Table 125 Asia Pacific: Gastrointestinal Stent Market, By Country/Region, 2015–2022 (USD Million)
Table 126 Asia Pacific: Market, By Product, 2015–2022 (USD Million)
Table 127 Asia Pacific: Gastrointestinal Stent Market, By Material, 2015–2022 (USD Million)
Table 128 Asia Pacific: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 129 Asia Pacific: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 130 Asia Pacific: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 131 Asia Pacific: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 132 China: GI Cancer Incidence Among Geriatric Population, By Type, (2012 vs 2030)
Table 133 China: Macroeconomic Indicators
Table 134 China: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 135 China: Market, By Material, 2015–2022 (USD Million)
Table 136 China: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 137 China: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 138 China: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 139 China: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 140 Japan: GI Cancer Incidence Among Geriatric Population, By Type, (2012 vs 2030)
Table 141 Japan: Macroeconomic Indicators
Table 142 Japan: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 143 Japan: Market, By Material, 2015–2022 (USD Million)
Table 144 Japan: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 145 Japan: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 146 Japan: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 147 Japan: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 148 India: Gastrointestinal Cancer Incidence, By Type (2012 vs 2030)
Table 149 India: Macroeconomic Indicators
Table 150 India: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 151 India: Market, By Material, 2015–2022 (USD Million)
Table 152 India: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 153 India: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 154 India: Gastrointestinal Cancer Stents Market, By Type, 2015–2022 (USD Million)
Table 155 India: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 156 RoAPAC: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 157 RoAPAC: Market, By Material, 2015–2022 (USD Million)
Table 158 RoAPAC: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 159 RoAPAC: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 160 RoAPAC: Gastrointestinal Cancer Stents Market, By Type, 2015–2022 (USD Million)
Table 161 RoAPAC: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 162 Latin America: Gastrointestinal Cancer Incidence, By Type, 2012 vs 2030
Table 163 Latin America: Macroeconomic Indicators
Table 164 Latin America: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 165 Latin America: Market, By Material, 2015–2022 (USD Million)
Table 166 Latin America: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 167 Latin America: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 168 Latin America: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 169 Latin America: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 170 Middle East & Africa: GI Cancer Incidence, By Type,2012 vs 2030
Table 171 Middle East and Africa: Gastrointestinal Stent Market, By Product, 2015–2022 (USD Million)
Table 172 Middle East and Africa: Market, By Material, 2015–2022 (USD Million)
Table 173 Middle East and Africa: Gastrointestinal Self-Expanding Metal Stents Market, By Type, 2015–2022 (USD Million)
Table 174 Middle East and Africa: Gastrointestinal Stent Market, By Disease, 2015–2022 (USD Million)
Table 175 Middle East and Africa: Gastrointestinal Cancer Stents Market, Bt Type, 2015–2022 (USD Million)
Table 176 Middle East and Africa: Gastrointestinal Stent Market, By End User, 2015–2022 (USD Million)
Table 177 Market Ranking of the Key Players in Gastrointestinal Stent Market, 2016


List of Figures (32 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation Methodology
Figure 3 Global Gastrointestinal Stent Market, By Product, 2017 vs 2022 (USD Million)
Figure 4 Global Gastrointestinal Stent Market, By Material, 2017 vs 2022 (USD Million)
Figure 5 Global Gastrointestinal Stent Market, By Disease Type, 2017 vs 2022 (USD Million)
Figure 6 Global Gastrointestinal Stent Market, By End User, 2017 vs 2022 (USD Million)
Figure 7 Geographical Snapshot of the Global Gastrointestinal Stent Market
Figure 8 Rising Preference for Minimally Invasive Procedures is Propelling Growth in the Gastrointestinal Stent Market
Figure 9 Colorectal Cancer Segment Commanded the Largest Share of the Gastrointestinal Cancer Stents Market in 2016
Figure 10 US Accounted for the Largest Share of the Gastrointestinal Stent Market in 2016
Figure 11 Biliary Diseases Segment Will Continue to Dominate the Gastrointestinal Stent Market By 2022
Figure 12 Asia Pacific to Witness the Highest Growth Rate in the Gastrointestinal Stent Market During the Forecast Period
Figure 13 Gastrointestinal Stent Market: Drivers, Opportunities, & Challenges
Figure 14 Global Geriatric Population, By Region, 2010 vs 2015 vs 2030
Figure 15 Global Geriatric Population, By Country, 2000 vs 2015
Figure 16 Overweight Adult Population, By Country, 2010 vs 2014 (% of Total Adult Population)
Figure 17 Ce Approval Process for Gastrointestinal Stents
Figure 18 Biliary Segment Will Continue to Dominate the Global Gastrointestinal Stent Market By 2022
Figure 19 Self-Expanding Metal Stents Segment Will Continue to Dominate the Global Gastrointestinal Stent Market By 2022
Figure 20 Biliary Diseases to Dominate Gastrointestinal Stent Market, By Disease Type in 2017
Figure 21 Hospitals Segment Will Continue to Dominate the Global Gastrointestinal Stent Market By 2022
Figure 22 Gastrointestinal Stent Market: Geographic Snapshot
Figure 23 North America: Gastrointestinal Stent Market Snapshot
Figure 24 Europe: Gastrointestinal Stent Market Snapshot
Figure 25 Key Developments in the Gastrointestinal Stent Market, 2014–2017
Figure 26 Boston Scientific: Company Snapshot
Figure 27 C.R. Bard: Company Snapshot
Figure 28 Becton, Dickinson and Company: Company Snapshot
Figure 29 Merit Medical Systems: Company Snapshot
Figure 30 Conmed: Company Snapshot
Figure 31 Cantel Medical: Company Snapshot (2017)
Figure 32 OlympUS: Company Snapshot

The global gastrointestinal stents market is projected to reach USD 452.6 million by 2022 from USD 353.4 million in 2017 at a CAGR of 5.1% from 2017 to 2022. The growth in the geriatric population, increasing preference for minimally invasive surgeries, and rising prevalence of GI cancers and diseases are the key factors driving the growth of this market.

A gastrointestinal stent is a cylindrical medical device primarily used as a safe and effective alternative to surgery or repetitive endoscopic procedures to widen a narrow or stenosed lumen in order maintain the patency of the lumen. Gastrointestinal stents are used in the treatment of various gastrointestinal diseases and disorders. They are special tubular devices implanted into gastrointestinal channels in the body to open up passages for body fluids or hold open the channels during surgery. GI stents are the most frequently used treatment modality for palliating dysphagia from gastrointestinal cancers. Endoscopic retrograde cholangiopancreatography (ERCP) is a key therapeutic tool for the insertion/implantation of GI stents.

Based on product, the global gastrointestinal stents market is broadly segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents. The market for pancreatic stent is expected to grow at the highest CAGR between 2017 and 2022. Among all GI stents, biliary stent is the most common. The large share of this segment is due to the high prevalence of pancreatic cancer and biliary diseases as well as the growth in the number of surgical procedures for the treatment of these diseases.

The GI stent market in APAC is expected to grow at the highest CAGR during the forecast period. The rapid growth in geriatric population, increasing prevalence of GI diseases, less stringent regulations, acceptance of advanced technologies, rising healthcare awareness, improving healthcare expenditure, and increasing demand for quality healthcare are supporting market growth in APAC.

Gastrointestinal / GI Stent Market

Rising adoption of GI stents in diseases such as biliary disease, inflammatory bowel disease, and gastrointestinal cancer drive the growth of GI stent market

Biliary Diseases

The treatment of biliary diseases involves endoscopic biliary stenting, which is meant to open up blockages in the bile duct. Gallstones in the gallbladder or within the bile ducts; inflammation of the pancreas; sclerosing cholangitis; tumors of the pancreas, gallbladder, bile duct, and liver; postoperative biliary leaks, and infections are the major clinical conditions for which biliary stents are primarily utilized.

Gastrointestinal Cancers

Advanced endoscopy can be used to insert stents (hollow tubes) into various sites of the GI tract in the patient with GI cancer and this has proved to be a major therapeutic advance. Stents can hold open strictured areas in the oesophagus, the biliary tree, the colon and the gastroduodenal region. Stents are usually positioned in order to overcome stricturing associated with cancerous tumors. They are used as definitive treatment for gastrointestinal cancer, as a bridge to surgery and for palliation of obstructive symptoms. Gastrointestinal cancers result in obstructions in the GI tract, through the formation of tumor cells. This market segment is categorized into colorectal cancer, stomach cancer, esophageal cancer, and pancreatic cancer.

Colorectal Cancer

Colorectal cancer is the third-most-common cancer and the second-leading cause of cancer deaths worldwide. According to the NCI, in 2017, it is estimated that there will be 135,430 new cases of colorectal cancer (8.0% of all new cancer cases) and an estimated 50,260 deaths (8.4% of all cancer deaths) in the US. According to the WHO, in 2014, almost 55% of the colorectal cancer cases occurred in developed countries. The highest estimated rates of colorectal cancer are in Australia/New Zealand—about 44.8 and 32.2 per 100,000 individuals in men and women, respectively. The growth of this segment is attributed to the increasing geriatric population and changing lifestyles, which are driving the prevalence of colorectal cancer.

Critical questions the report answers:

  • Where will all these developments take the industry in the mid to long term?
  • What are the upcoming industry applications for GI stents?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Complications associated with GI stent implementation is a major factor restraining the growth of the market. The major complications associated with the implementation of gastrointestinal stents include stent misplacement or displacement, bleeding, obstruction, perforation, stent fracture or collapse, and infection. Misplacement or displacement of stents occurs more frequently in covered stents. Stent migration generally causes obstruction, hemorrhage, and perforation. Fractures of wires in stents can cause gastrointestinal bleeding and recurrent biliary obstruction. Granulation tissue formation can be mild enough to remain asymptomatic, moderate, or severe enough to cause certain clinical complications.

The prominent players in the global gastrointestinal stents market are Boston Scientific (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cook Group (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), M.I. Tech (South Korea), and Diagmed Healthcare (UK). These players are increasingly undertaking acquisitions, and product launches to develop and introduce new technologies and products in the market.

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement


-
Request for FREE Sample of this report Send Request